- Home
- ZH vs BDTX Comparison
ZH vs BDTX Comparison
Compare ZH & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZH
- BDTX
- Stock Information
- Founded
- ZH 2011
- BDTX 2014
- Country
- ZH China
- BDTX United States
- Employees
- ZH N/A
- BDTX N/A
- Industry
- ZH Business Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZH Consumer Discretionary
- BDTX Health Care
- Exchange
- ZH Nasdaq
- BDTX Nasdaq
- Market Cap
- ZH 387.2M
- BDTX 323.2M
- IPO Year
- ZH 2021
- BDTX 2020
- Fundamental
- Price
- ZH $3.58
- BDTX $3.31
- Analyst Decision
- ZH Strong Buy
- BDTX Strong Buy
- Analyst Count
- ZH 2
- BDTX 4
- Target Price
- ZH $6.00
- BDTX $15.50
- AVG Volume (30 Days)
- ZH 798.2K
- BDTX 932.5K
- Earning Date
- ZH 11-27-2024
- BDTX 11-04-2024
- Dividend Yield
- ZH N/A
- BDTX N/A
- EPS Growth
- ZH N/A
- BDTX N/A
- EPS
- ZH N/A
- BDTX N/A
- Revenue
- ZH $558,027,906.00
- BDTX N/A
- Revenue This Year
- ZH N/A
- BDTX N/A
- Revenue Next Year
- ZH $7.55
- BDTX N/A
- P/E Ratio
- ZH N/A
- BDTX N/A
- Revenue Growth
- ZH N/A
- BDTX N/A
- 52 Week Low
- ZH $2.55
- BDTX $1.62
- 52 Week High
- ZH $6.36
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- ZH 46.23
- BDTX 33.12
- Support Level
- ZH $3.56
- BDTX $3.13
- Resistance Level
- ZH $3.71
- BDTX $3.42
- Average True Range (ATR)
- ZH 0.23
- BDTX 0.24
- MACD
- ZH -0.08
- BDTX 0.02
- Stochastic Oscillator
- ZH 12.50
- BDTX 20.93
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.